Professor Sir Munir Pirmohamed MB ChB (Hons), MRCP, PhD, FRCP, FRCP(E), FBPharmacolS Professor (Clin,Hcc) Pharmacology & Therapeutics +44 (0)151 794 5549 Work email Munirp@liverpool.ac.uk Personal Websitehttp://liv.ac.uk/pharmacogenetics/ About Research Publications Teaching Professional Activities Teaching Modules for 2023-24 GRAND CHALLENGES IN BIOLOGY Module code: LIFE105 Role: Teaching Supervised ThesesAdverse Drug Reactions in Hospitalised ChildrenAn Investigation into the Immunological Mechanisms of Immune Related Adverse Events Associated with Oncological Immune Checkpoint InhibitorsAtypical Antipsychotic (AAP)-induced Metabolic Toxicity: Study of Mechanisms, Biomarkers and Reversal StrategiesCHARACTERISATION OF DRUG-SPECIFIC T-CELLS TOWARDS A MECHANISTIC INSIGHT OF DRUG HYPERSENSITIVITY REACTIONSCarbamazepine Hypersensitivity: Linking Metabolism to the Immune ResponseChemotherapy Induced Peripheral Neuropathy: Clinical Aspects and Molecular GeneticsExamining the impact of precision medicine on health disparitiesImpact of Clostridium difficile infection: clinical and economic perspectivesImproved Signal Detection of Drug-Drug Interactions in the Post-Marketing Phase: Reference Sets, Quantitative Methods and Systems Pharmacology AspectsInvestigating Mitochondrial Impairment as a Mechanism of Statin-Induced Muscle ToxicityInvestigating the impact of OCT transporter genotype on metformin-induced vitamin B12 deficiencyInvestigating the role of eyes absent homolog 1 (EYA1) in aspirin-induced gastric ulcerationInvestigation into the mechanisms of Stevens-Johnson syndrome and toxic epidermal necrolysisInvestigation of immunogenetic risk factors for carbamazepine-induced hypersensitivity reactionsMechanisms of lower gastrointestinal toxicity caused by tyrosine kinase inhibitorsMolecular Identification Of Clozapine TransportersMultimorbidity and Polypharmacy: A Health Informatics ApproachMultimorbidity and Polypharmacy: A Health Informatics ApproachOptimisation of Anti-Platelet Therapy in Acute Coronary SyndromesPHARMACOGENETIC AND PROTEIN BIOMARKERS ASSOCIATED WITH TENOFOVIR- INDUCED RENAL TOXICITY IN HIV-POSITIVE PATIENTS IN ZAMBIAPharmacogenomics implementation into the UK National Health Service: Lessons and Successes from the PREPARE projectStatin-associated muscle toxicity: clinical and genomic perspectivesStrategies to Improve the Detection and Reporting of Adverse Drug ReactionsThe PERMIT Project: Personalised Renal Function Monitoring via Information TechnologyThe adipocyte plasma membrane proteome and its role in drug-induced metabolic toxicityThe implementation of pharmacogenetics: evidence and preferencesThe role of SLC4A4 in the pathogenesis of NSAID-induced upper gastrointestinal injuryVeterinary pharmacovigilance: A health informatics approachWarfarin anticoagulation in patients with cardiovascular disease in sub-Saharan Africa
